Each year, the National Institutes of Health invests approximately $1.5 billion in stem cell research. Cedars-Sinai has been honored to be a recipient of some of these highly competitive funds, which have paved the way for exciting advances in the field of regenerative medicine.
From the Dean
Curing the incurable is the physician-scientist’s dream. At Cedars-Sinai, our scientists and clinicians make it a priority to engage with one another to translate discoveries into health-saving therapies.
The recently launched Cedars-Sinai Precision Health efficiently delivers precise and personalized healthcare solutions to patients. Precision medicine requires integration of advanced technology, the latest biomedical discoveries, and rigorous bioinformatics to tailor disease treatments and prevention strategies to each individual.
Shlomo Meldmed, MD, on the $600 million Campaign for Cedars-Sinai, which focuses on five strategic initiatives: disease prevention and control; precision medicine and targeted therapies; aging and longevity; innovations in healthcare and technology; and education and training.
When I was a medical resident in the 1960s, hand hygiene was barely discussed as an imperative. We were taught to wash our hands before seeing patients, but we rarely saw this behavior modeled by senior physicians. Today, medical institutions Read On
Can a structure of steel and stone determine the course of medical discovery in the age of genomics and nanomedi- cine? That question is posed with the recent opening of Cedars-Sinai’s Advanced Health Sciences Pavilion. For answers, we need to Read On
I learned the word “insulin” when I was just 7 years old. That year, my young father was diagnosed with diabetes. At an age when most children are frightened of needles, my siblings and I grew accustomed to watching him Read On